15 Posts Not to Miss from ESMO TAT Asia 2026
A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026
STAMP Inhibitors Against CML: Prof. Timothy Hughes
Muna Al-Khaifi: Translating Evidence Into Everyday Practice for Cancer-Related Fatigue
Gustavo Monnerat: 2 Blinded Clinicians. 6 AI Systems. 100 Real Patient Questions
Andy Whitfield’s Final Battle: The Spartacus Star and Stage IV Non-Hodgkin Lymphoma
Christopher Conn: Honored to Step Into the Role of Global Head of Diagnostics at Amgen
FDA Rare Disease Endpoint Advancement Pilot Program Accepting Applications Through June 30, 2026
